Andrea Javor Wrote About Her Experience With Ozempic
For The Guardian, Andrea Javor shared how she wanted to feel like she wasn’t “alone in missing out on the weight loss benefit of alleged “miracle drugs” like Ozempic.”
Javor told Study Hall, “As a diabetic, I was on GLP1 meds for years but wasn’t losing weight. I pitched the idea to my editor at The Guardian who said yes quickly to research on the “non-responder” community. What I love about working with this editor in particular is she allows for the deep personal story wrapped around the reporting.”
Javor’s writing has appeared in Slate, Newsweek, and Vogue.
Subscribe to Study Hall for Opportunity, knowledge, and community
$532.50 is the average payment via the Study Hall marketplace, where freelance opportunities from top publications are posted. Members also get access to a media digest newsletter, community networking spaces, paywalled content about the media industry from a worker's perspective, and a database of 1000 commissioning editor contacts at publications around the world. Click here to learn more.